Table 3.
Treatment | Mode of action | Schedule | Clearance rate (%) | Recurrence rate (%) | Advantages | Disadvantages | Refs | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ablative techniques | ||||||||||||
Cryotherapy | Liquid nitrogen freezes and destroys lesions | Applied directly to lesions; repeat for two or three cycles | 46–96 | 18–39 |
|
|
20, 45, 46, 47, 48, 49 | |||||
CO2 and Nd:YAG laser | Laser vaporizes lesions | Under local anaesthesia, protocol depends on type of laser | 23–95 | 2.5–77 |
|
|
20, 48, 50 | |||||
Electrocautery | High‐frequency electrical currents cause thermal damage to infected tissue | Under local anaesthesia, base of lesion excised; repeat as required | 35–94 | 20–25 |
|
|
18, 20, 49, 51 | |||||
Surgery | Scissor or scalpel excision | Under local or general anaesthesia; base of lesion excised | 89–93 | 18–65 |
|
|
52, 53, 54 | |||||
Trichloroacetic acid (33–50%) | Acid induces a chemical burn | One to three times per week; repeat as necessary | 70–100 | 18–36 |
|
|
20, 45, 47, 55 | |||||
Immunotherapies | ||||||||||||
Imiquimod 5% | Immunomodulator: stimulates interferon and cytokine production | Three nights per week for up to 16 weeks or longer | 35–75 | 6 |
|
|
20, 21, 22, 23, 24, 25, 26, 41, 56, 57, 58, 59, 60, 61, 62 | |||||
Imiquimod 3.75% | Immunomodulator: stimulates interferon and cytokine production | Once daily before bedtime for up to 8 weeks | 19–37 | 15–19 |
|
|
20, 27, 28, 29 | |||||
Sinecatechins 10% and 15% | Inflammatory response modulator | Three times daily for up to 16 weeks | 40–81% | 7–12 |
|
|
20, 30, 31, 32, 33, 34 | |||||
Other topical therapy | ||||||||||||
Podophyllotoxin 0.5% (alcoholic solution) 0.15% (cream) | Antimitotic agent induces tissue necrosis | Twice‐daily to affected areas for 3 consecutive days per week; discontinue for 4 days; repeat for up to 4 weeks | 45–94 | 11–100 |
|
|
20, 31, 35, 36, 37, 38, 39, 40, 42, 43, 44, 63 | |||||
Nitric–zinc complex topical solution | Induces a caustic effect on the wart through mummification and protein denaturation/coagulation action | Once or up to four times; repeat at 2‐week intervals if needed | 90–99 | Not evaluated |
|
|
64 |
AGW, anogenital warts.